Media Summary: Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for
Intermediate Risk Do You Need - Detailed Analysis & Overview
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for PCRI's Executive Director, Mark Scholz, MD, compares different treatments for men with Teal stage ( MUSC Hollings Cancer Center radiation oncologist Dr. David Marshall reviews the treatment options for Join Dr. Art Rastinehad in this enlightening session tailored for patients facing unfavorable Eric Klein, MD, Glickman Urology & Kidney Institute, Cleveland, OH, discusses novel tools for the management of ... Christoph Röllig, MD, MSc, Dresden University of Technology, Dresden, Germany, shares some results from a study which ...
Medical oncologist Mark Scholz, MD answers patient's questions from our YouTube comments on the topics of active surveillance ... Dr. Mark Emberton presented “Focal Therapy for Men with David T. Marshall, M.D., is a board-certified radiation oncologist, specializing in genitourinary and gastrointestinal cancers at ... Dr. Larry Goldenberg, Professor & Head, Department of Urologic Sciences, and Director of Development, the Vancouver Prostate ... Active Surveillance for Prostate Cancer: Is It Right for
